"Hormones Should Not Be Balanced": The $11.6M Wearable Rewriting Women's Health with Jenny Duan of Clair Health

What does it actually take to raise $11.6M at 21, sell out 33,000 pre-sales before launch, and build a hormone wearable that challenges everything the wellness industry has been telling women about their bodies?In this episode of The Clinical Tea, Kristina sits down with Jenny Duan, founder of Clair Health, the world's first wearable hormone tracker, for the conversation nobody else is having about women's health, femtech, and what it really means to build in stealth before the world is ready for you.Jenny and Kristina get into:Why "hormones should not be balanced" — and what that means for every supplement, tracker, and wellness product marketed to womenBuilding and selling out 33,000 pre-sales before a single public announcementHiring your first two employees without knowing if you can make payroll — and doing it anywayPitching a women's health brand to investors who have never had to think about women's biologyWhy women's health has been dismissed as "niche" — and why that is one of the most expensive mistakes in healthcare historyThe transition from wellness device to FDA-cleared medical device, and what clinical validation actually requiresRaising an $11.6M seed round led by Khosla Ventures at 21 years oldThis is the episode for every woman who has worn a fitness tracker and wondered why it never quite fit. For every founder who has been told their market is too small. And for every person who has been sold "hormone balance" by a brand that couldn't define what that means.New episodes of The Clinical Tea drop weekly. Subscribe on Spotify and Apple Podcasts so you never miss the tea. ☕🔬